These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17299400)

  • 1. The continuing contribution of gene marking to cell and gene therapy.
    Tey SK; Brenner MK
    Mol Ther; 2007 Apr; 15(4):666-76. PubMed ID: 17299400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of gene marking technologies in oncology.
    Brenner M
    Forum (Genova); 1998; 8(4):342-53. PubMed ID: 9863029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of marker genes into hemopoietic progenitor cells.
    Brenner MK; Heslop HE; Rill D; Li C; Smith C; Krance R; Rooney C
    Cytokines Mol Ther; 1996 Sep; 2(3):193-200. PubMed ID: 9384704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of marker gene studies to hemopoietic stem cell therapies.
    Brenner MK
    Stem Cells; 1995 Sep; 13(5):453-61. PubMed ID: 8528094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.
    Bordignon C; Bonini C; Verzeletti S; Nobili N; Maggioni D; Traversari C; Giavazzi R; Servida P; Zappone E; Benazzi E
    Hum Gene Ther; 1995 Jun; 6(6):813-9. PubMed ID: 7548281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors.
    Haviernik P; Bunting KD
    Curr Gene Ther; 2004 Sep; 4(3):263-76. PubMed ID: 15384940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of gene marking to cell and gene therapies.
    Barese CN; Dunbar CE
    Hum Gene Ther; 2011 Jun; 22(6):659-68. PubMed ID: 21261461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically marking human cells--results of the first clinical gene transfer studies.
    Cai Q; Rubin JT; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):125-36. PubMed ID: 7621260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of gene marking in bone marrow transplantation.
    Heslop HE; Rooney CM; Rill DR; Krance RA; Brenner MK
    Cancer Detect Prev; 1996; 20(2):108-13. PubMed ID: 8706035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic marking and manipulation of hematopoietic progenitor cells using retroviral vectors.
    Brenner MK
    Immunomethods; 1994 Dec; 5(3):204-10. PubMed ID: 7780687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is retroviral gene marking too dangerous to use?
    Brenner MK; Heslop HE
    Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
    [No Abstract]   [Full Text] [Related]  

  • 12. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.
    Kustikova O; Fehse B; Modlich U; Yang M; Düllmann J; Kamino K; von Neuhoff N; Schlegelberger B; Li Z; Baum C
    Science; 2005 May; 308(5725):1171-4. PubMed ID: 15905401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy-based treatment for HIV-positive patients with malignancies.
    Kang EM; De Witte M; Malech H; Morgan RA; Carter C; Leitman SF; Childs R; Barrett AJ; Little R; Tisdale JF
    J Hematother Stem Cell Res; 2002 Oct; 11(5):809-16. PubMed ID: 12427287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transduction of CD34+ cells from the bone marrow of HIV-1-infected children: comparative marking by an RRE decoy gene and a neutral gene.
    Hum Gene Ther; 2000 Jul; 11(11):1577-90. PubMed ID: 10945771
    [No Abstract]   [Full Text] [Related]  

  • 15. Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer.
    Dunbar CE; Nienhuis AW; Stewart FM; Quesenberry P; O'Shaughnessy J; Cowan K; Cottler-Fox M; Leitman S; Goodman S; Sorrentino BP
    Hum Gene Ther; 1993 Apr; 4(2):205-22. PubMed ID: 8098622
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene marking to improve the outcome of autologous bone marrow transplantation.
    Brenner MK; Rill DR
    J Hematother; 1994; 3(1):33-6. PubMed ID: 7922006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
    Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.
    Plavec I; Voytovich A; Moss K; Webster D; Hanley MB; Escaich S; Ho KE; Böhnlein E; DiGiusto DL
    Gene Ther; 1996 Aug; 3(8):717-24. PubMed ID: 8854097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene marking.
    Brenner M
    Hum Gene Ther; 1996 Oct; 7(16):1927-36. PubMed ID: 8930652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered T cell therapies.
    Field AC; Qasim W
    Expert Rev Mol Med; 2015 Nov; 17():e19. PubMed ID: 26530808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.